GNI Ltd.

1 similar search for GNI Ltd.

GNI LTD

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

330 documents for GNI Ltd.

- GNI Ltd. and Shanghai Genomics Merge; Japanese and Chinese Biotech Companies Combine to Increase R&D Productivity and Market Opportunity.
TOKYO & SHANGHAI, China -- GNI Ltd. and Shanghai Genomics announced today that the two companies have formed a merger. GNI concurrently raised a priva...
- Business Wire
- June 20, 2005
- GNI Ltd. and the University of Auckland's UniServices Ltd. Announce Collaboration; Research Will Focus on Melanoma and Breast Cancer.
TOKYO -- URL in ninth graph of release dated Sept. 5, 2006 should read: www.gene-networks.com (sted www.genenetworks.com). The corrected release rea...
- Business Wire
- September 07, 2006
- GNI Ltd -- Gene Networks International -- Announces Exclusive Patent Licence & Collaborative R&D Agreement with University Of Cambridge.
TOKYO -- Research Focuses on Angiogenesis and Inflammation Research GNI Ltd. (Gene Networks International), a global pharmaceutical development grou...
- Business Wire
- October 18, 2004

- GNI, Ltd. --Gene Networks International-- Enters R&D Collaboration with Toyama Chemical Co., Ltd. to Use Systems Pharmacology Platform for Drug Discovery.
TOKYO -- GNI Ltd. (Gene Networks International), a global pharmaceutical development group with R&D facilities in Kurume, Japan and Cambridge, UK, ann...
- Business Wire
- October 11, 2004
- GNI Ltd. -- Gene Networks International -- Announces Formation of Scientific Advisory Board; Global Scientists Key to Strategy of Systems Pharmacology & Gene Networks Company.
TOKYO -- GNI Ltd. (Gene Networks International), a global pharmaceutical development group, announced today its Scientific Advisory Board. This distin...
- Business Wire
- September 27, 2004
- Dorbest Ltd. v. United States, (2011)
Slip Op. 11-14 UNITED STATES COURT OF INTERNATIONAL TRADE Before: Pogue, Chief JudgeConsol. Ct. No. 05-00003 OPINION AND ORDER[Co...
- United States Court of International Trade
- GNI Announces IND Approval in China for Novel Liver Disease Drug F351.
TOKYO -- GNI Ltd (TOKYO:2160), a leading biopharmaceutical company ...
- Business Wire
- November 21, 2007
- Antidumping Methodologies in Proceedings Involving Non-Market Economies:
...Federal Circuit (``CAFC''), in Dorbest Ltd. v. United States, 604 F. 3d 1363, 1372 (Fed. Cir....
- FR, February 18, 2011
- Notices
- International Trade Administration
- GNI Forms Marketing Alliance with Wako Pure Chemical.
...TOKYO -- GNI Ltd, a leading biopharmaceutical company in Asia, toda...
- Business Wire
- January 18, 2007
- EpiCept and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia.
...-- Regulatory News: . GNI Ltd, a leading biopharmaceutical company in Japan and ...
- Business Wire
- July 17, 2008